Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 5c/Share; Updates on Cash Position

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 5c/Share; Updates on Cash Position

Inovio Pharmaceuticals (INO) Posts Q1 Results with Data Ahead - Maxim Group

May 12, 2014 1:22 PM EDT

Maxim Group analyst Jason Kolbert reiterated a Buy rating and $6 price target on Inovio Pharmaceuticals (NYSE: INO) following Q1 results. The company posted revenues of $2.4M versus operating expenses of $12M and had $117M in cash and cash equivalents at the quarter's end.

On upcoming data, Kolbert notes, "As the... More